544 related articles for article (PubMed ID: 26842468)
21. Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.
Wang S; Ljubimov AV; Jin L; Pfeffer K; Kronenberg M; Ghiasi H
J Virol; 2018 Dec; 92(24):. PubMed ID: 30282707
[TBL] [Abstract][Full Text] [Related]
22. Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells.
Treat BR; Bidula SM; Ramachandran S; St Leger AJ; Hendricks RL; Kinchington PR
PLoS Pathog; 2017 Dec; 13(12):e1006732. PubMed ID: 29206240
[TBL] [Abstract][Full Text] [Related]
23. Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice.
St Leger AJ; Peters B; Sidney J; Sette A; Hendricks RL
J Immunol; 2011 Apr; 186(7):3927-33. PubMed ID: 21357536
[TBL] [Abstract][Full Text] [Related]
24. A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.
Chentoufi AA; Dasgupta G; Christensen ND; Hu J; Choudhury ZS; Azeem A; Jester JV; Nesburn AB; Wechsler SL; BenMohamed L
J Immunol; 2010 Mar; 184(5):2561-71. PubMed ID: 20124097
[TBL] [Abstract][Full Text] [Related]
25. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.
van Velzen M; Jing L; Osterhaus AD; Sette A; Koelle DM; Verjans GM
PLoS Pathog; 2013 Aug; 9(8):e1003547. PubMed ID: 23966859
[TBL] [Abstract][Full Text] [Related]
26. A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.
Perng GC; Maguen B; Jin L; Mott KR; Osorio N; Slanina SM; Yukht A; Ghiasi H; Nesburn AB; Inman M; Henderson G; Jones C; Wechsler SL
J Virol; 2002 Feb; 76(3):1224-35. PubMed ID: 11773398
[TBL] [Abstract][Full Text] [Related]
27. The locus encompassing the latency-associated transcript of herpes simplex virus type 1 interferes with and delays interferon expression in productively infected neuroblastoma cells and trigeminal Ganglia of acutely infected mice.
Peng W; Henderson G; Inman M; BenMohamed L; Perng GC; Wechsler SL; Jones C
J Virol; 2005 May; 79(10):6162-71. PubMed ID: 15858001
[TBL] [Abstract][Full Text] [Related]
28. Coregulatory interactions among CD8α dendritic cells, the latency-associated transcript, and programmed death 1 contribute to higher levels of herpes simplex virus 1 latency.
Mott KR; Allen SJ; Zandian M; Ghiasi H
J Virol; 2014 Jun; 88(12):6599-610. PubMed ID: 24672046
[TBL] [Abstract][Full Text] [Related]
29. Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglion.
Ramachandran S; Davoli KA; Yee MB; Hendricks RL; Kinchington PR
J Virol; 2010 Sep; 84(17):8811-20. PubMed ID: 20573821
[TBL] [Abstract][Full Text] [Related]
30. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.
Halford WP; Schaffer PA
J Virol; 2001 Apr; 75(7):3240-9. PubMed ID: 11238850
[TBL] [Abstract][Full Text] [Related]
31. PD-L1/B7-H1 regulates the survival but not the function of CD8+ T cells in herpes simplex virus type 1 latently infected trigeminal ganglia.
Jeon S; St Leger AJ; Cherpes TL; Sheridan BS; Hendricks RL
J Immunol; 2013 Jun; 190(12):6277-86. PubMed ID: 23656736
[TBL] [Abstract][Full Text] [Related]
32. The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits.
Perng GC; Slanina SM; Yukht A; Ghiasi H; Nesburn AB; Wechsler SL
J Virol; 2000 Feb; 74(4):1885-91. PubMed ID: 10644361
[TBL] [Abstract][Full Text] [Related]
33. Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.
Matundan H; Mott KR; Ghiasi H
J Virol; 2014 Jul; 88(14):8016-27. PubMed ID: 24807710
[TBL] [Abstract][Full Text] [Related]
34. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J
J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084
[TBL] [Abstract][Full Text] [Related]
35. Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.
BenMohamed L; Osorio N; Srivastava R; Khan AA; Simpson JL; Wechsler SL
J Neurovirol; 2015 Oct; 21(5):508-17. PubMed ID: 26002839
[TBL] [Abstract][Full Text] [Related]
36. Herpes simplex virus type 1 serum neutralizing antibody titers increase during latency in rabbits latently infected with latency-associated transcript (LAT)-positive but not LAT-negative viruses.
Perng GC; Slanina SM; Yukht A; Ghiasi H; Nesburn AB; Wechsler SL
J Virol; 1999 Nov; 73(11):9669-72. PubMed ID: 10516082
[TBL] [Abstract][Full Text] [Related]
37. Herpes Simplex Virus 1-Specific CD8
Treat BR; Bidula SM; St Leger AJ; Hendricks RL; Kinchington PR
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826989
[TBL] [Abstract][Full Text] [Related]
38. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.
Khanna KM; Bonneau RH; Kinchington PR; Hendricks RL
Immunity; 2003 May; 18(5):593-603. PubMed ID: 12753737
[TBL] [Abstract][Full Text] [Related]
39. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.
Liu T; Khanna KM; Carriere BN; Hendricks RL
J Virol; 2001 Nov; 75(22):11178-84. PubMed ID: 11602757
[TBL] [Abstract][Full Text] [Related]
40. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
Srivastava R; Khan AA; Spencer D; Vahed H; Lopes PP; Thai NT; Wang C; Pham TT; Huang J; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
J Immunol; 2015 Mar; 194(5):2232-48. PubMed ID: 25617474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
